Nicola Gilmour

Nicola Gilmour

Auto-generated profile, based on publicly available information

Nicola Gilmour

Unilever, Colworth Science Park, Bedford, MK44 1LQ, United Kingdom

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in Regulatory Toxicology and Pharmacology
Verified
Journal Article
Closed access
NGNicola Gilmour
Nicola Gilmour
PKPetra Susanne Kern
Petra Susanne Kern
NANathalie Alépée
Nathalie Alépée
FBFanny Boislève
Fanny Boislève
DBDagmar Bury
Dagmar Bury
MKMartina Klaric
Martina Klaric

17 March 2022 in Regulatory Toxicology and Pharmacology
Verified
Journal Article
Closed access
NGN. Gilmour
N. Gilmour
JRJ. Reynolds
J. Reynolds
KPK. Przybylak
K. Przybylak
MAM. Aleksic
M. Aleksic
NAN. Aptula
N. Aptula
GMG. Maxwell
G. Maxwell

7 December 2018 in Contact Dermatitis
Verified
Journal Article
Open access
PDF file
NGNicola Gilmour
Nicola Gilmour
IKIan Kimber
Ian Kimber
JWJason Williams
Jason Williams
GMGavin Maxwell
Gavin Maxwell
At the ESCD congress held in Manchester in 2016, a session was organized to encourage more dialogue between clinicians with expertise in skin sensitization and toxicologists seeking to provide effective risk assessment to prevent human health issues. That session focused on the remaining uncertainties regarding the induction and regulation of skin sensitization in humans, and the opportunities and challenges associated with the refinement and improvement of risk assessment methodologies. This short article, prompted by those discussions, debates what the authors regard as being among the most important and most intriguing uncertainties about skin sensitization and allergic contact dermatitis in humans, and the most significant opportunities for improving risk assessment. The aim has been to provide a basis for mapping out the areas that might benefit from a closer alignment between the relevant clinical community and toxicologists charged with the responsibility of ensuring that skin sensitization risks are understood and managed.

1 February 2019 in Computational Toxicology
Verified
Journal Article
Open access
JRJoe Reynolds
Joe Reynolds
CMCameron MacKay
Cameron MacKay
NGNicola Gilmour
Nicola Gilmour
DMDavid Miguel-Vilumbrales
David Miguel-Vilumbrales
GMGavin Maxwell
Gavin Maxwell

1 January 2023 in ALTEX
Verified
Journal Article
Open access
NGNicola Gilmour
Nicola Gilmour
Cosmetic products must be safe for their intended use. Regulatory bans on animal testing for new ingredients has resulted in a shift towards the use of new approach methodologies (NAM), such as in silico predictions and in chemico/in vitro data. Defined Approaches (DA) have been developed to interpret combinations of NAM to provide information on skin sensitisation hazard and potency, three having been adopted within OECD Guideline 497. However, the challenge remains as to how DA can be used to derive a quantitative point of departure for use in next generation risk assessments (NGRA). Here we provide an update to our previously published NGRA framework and present two hypothetical consumer risk assessment scenarios (rinse-off and leave-on) on one case study ingredient. Diethanolamine (DEA) was selected as the case study ingredient based upon the existing NAM information demonstrating differences with respect to the outcomes from in silico predictions and in chemico / in vitro data. Seven DA were applied, and these differences resulted in divergent DA outcomes and reduced confidence with respect to the hazard potential and potency predictions. Risk assessment conclusion for the rinse-off exposure led to an overall decision of safe for all DA applied. Risk assessment conclusion for the higher leave-on exposure was safe when based upon some DA but unsafe for others. The reasons for this were evaluated, as well as the inherent uncertainty from the use of each NAM and DA in the risk assessment, enabling further refinement of our NGRA framework.

18 April 2022 in Regulatory Toxicology and Pharmacology
Verified
Journal Article
Open access
SHSebastian Hoffmann
Sebastian Hoffmann
NANathalie Alépée
Nathalie Alépée
NGNicola Gilmour
Nicola Gilmour
PKPetra Susanne Kern
Petra Susanne Kern
EVErwin van Vliet
Erwin van Vliet
MCMalda Al Chaar
Malda Al Chaar
The assessment of skin sensitisation is a key requirement in all regulated sectors, with the European Union's regulation of cosmetic ingredients being most challenging, since it requires quantitative skin sensitisation assessment based on new approach methodologies (NAMs). To address this challenge, an in-depth and harmonised understanding of NAMs is fundamental to inform the assessment. Therefore, we compiled a database of NAMs, and in vivo (human and local lymph node assay) reference data. Here, we expanded this database with 41 substances highly relevant for cosmetic industry. These structurally different substances were tested in six NAMs (Direct Peptide Reactivity Assay, KeratinoSens™, human Cell Line Activation Test, U-SENS™, SENS-IS, Peroxidase Peptide Reactivity Assay). Our analysis revealed that the substances could be tested without technical limitations, but were generally overpredicted when compared to reference results. Reasons for this reduced predictivity were explored through pairwise NAM comparisons and association of overprediction with hydrophobicity. We conclude that more detailed understanding of how NAMs apply to a wider range of substances is needed. This would support a flexible and informed choice of NAMs to be optimally applied in the context of a next generation risk assessment framework, ultimately contributing to the characterisation and reduction of uncertainty.